The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review.
The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review.
复制标题
口服营养保健品作为辅助治疗减少异维A酸副作用的作用：系统评价。
DOI：
10.1016/j.jaad.2023.10.037
复制
发表时间：
2024
影响因子：
13.8
通讯作者：
Barbieri,JohnS
中科院分区：
文献类型：
--
作者：
Shields,Ali;Ly,Sophia;Wafae,Bruna;Chang,Yu-Feng;Manjaly,Priya;Archila,Marjorie;Heinrich,Christina;Drake,Lara;Mostaghimi,Arash;Barbieri,JohnS
利益冲突：John S Barbieri因与本研究无关的工作而从Dexcel Pharma获得咨询费22。Arash Mostaghimi已收到辉瑞公司支付的23 ALTO、BELA和BETA工具许可使用费，并参与了Incyte、24 Lilly、Concert和Aclaris的脱发相关临床试验。此外，Mostaghimi博士还收到了辉瑞、25 Concert、礼来、AbbVie、希姆斯和她、Digital Diagnostics和Bioniz的咨询费。IRB批准状态：不适用。27
Conflicts of Interest: John S Barbieri has received consulting fees from Dexcel Pharma for work unrelated 22 to the present study. Arash Mostaghimi has received royalty payments from Pfizer for licensing of the 23 ALTO, BELA, and BETA tools and has participated in clinical trials related to alopecia from Incyte, 24 Lilly, Concert, and Aclaris. In addition, Dr. Mostaghimi has received consulting fees from Pfizer, 25 Concert, Lilly, AbbVie, hims and hers, Digital Diagnostics, and Bioniz. 26 IRB approval status: Not applicable. 27